Greenleaf Trust Acquires 588 Shares of The Allstate Co. (NYSE:ALL)

Greenleaf Trust lifted its holdings in The Allstate Co. (NYSE:ALL) by 5.8% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 10,687 shares of the insurance provider’s stock after buying an additional 588 shares during the period. Greenleaf Trust’s holdings in Allstate were worth $1,496,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in ALL. Gradient Investments LLC lifted its position in Allstate by 1.6% during the fourth quarter. Gradient Investments LLC now owns 4,130 shares of the insurance provider’s stock valued at $578,000 after acquiring an additional 66 shares during the last quarter. SVB Wealth LLC lifted its holdings in shares of Allstate by 1.2% during the 4th quarter. SVB Wealth LLC now owns 6,169 shares of the insurance provider’s stock valued at $864,000 after purchasing an additional 72 shares during the last quarter. Apollon Wealth Management LLC boosted its position in shares of Allstate by 2.5% in the 4th quarter. Apollon Wealth Management LLC now owns 3,214 shares of the insurance provider’s stock worth $436,000 after purchasing an additional 78 shares in the last quarter. AdvisorNet Financial Inc grew its stake in Allstate by 1.5% during the 4th quarter. AdvisorNet Financial Inc now owns 5,384 shares of the insurance provider’s stock worth $754,000 after buying an additional 82 shares during the last quarter. Finally, Carmel Capital Partners LLC increased its position in Allstate by 19.2% during the 3rd quarter. Carmel Capital Partners LLC now owns 516 shares of the insurance provider’s stock valued at $57,000 after buying an additional 83 shares in the last quarter. 76.47% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In other news, insider John E. Dugenske sold 31,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 26th. The stock was sold at an average price of $170.20, for a total value of $5,276,200.00. Following the completion of the sale, the insider now directly owns 63,731 shares in the company, valued at $10,847,016.20. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other Allstate news, CAO John C. Pintozzi sold 4,000 shares of the stock in a transaction on Tuesday, February 27th. The shares were sold at an average price of $159.47, for a total transaction of $637,880.00. Following the transaction, the chief accounting officer now directly owns 10,736 shares of the company’s stock, valued at $1,712,069.92. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, insider John E. Dugenske sold 31,000 shares of Allstate stock in a transaction dated Tuesday, March 26th. The shares were sold at an average price of $170.20, for a total transaction of $5,276,200.00. Following the completion of the sale, the insider now owns 63,731 shares in the company, valued at approximately $10,847,016.20. The disclosure for this sale can be found here. 1.80% of the stock is currently owned by insiders.

Allstate Trading Up 2.3 %

Allstate stock opened at $172.96 on Friday. The firm has a market cap of $45.50 billion, a PE ratio of -139.48, a P/E/G ratio of 0.41 and a beta of 0.52. The Allstate Co. has a 12 month low of $100.57 and a 12 month high of $174.57. The stock’s 50 day simple moving average is $163.84 and its two-hundred day simple moving average is $147.29. The company has a current ratio of 0.37, a quick ratio of 0.37 and a debt-to-equity ratio of 0.51.

Allstate (NYSE:ALL) last announced its quarterly earnings results on Thursday, February 8th. The insurance provider reported $5.82 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.87 by $1.95. The firm had revenue of $14.83 billion for the quarter, compared to the consensus estimate of $12.69 billion. Allstate had a negative net margin of 0.33% and a positive return on equity of 2.67%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm posted ($1.36) earnings per share. Analysts anticipate that The Allstate Co. will post 13.49 earnings per share for the current year.

Allstate Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, April 1st. Investors of record on Monday, March 4th were paid a $0.92 dividend. This represents a $3.68 annualized dividend and a dividend yield of 2.13%. The ex-dividend date was Friday, March 1st. This is a positive change from Allstate’s previous quarterly dividend of $0.89. Allstate’s payout ratio is currently -296.77%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ALL. Evercore ISI boosted their price target on Allstate from $166.00 to $173.00 and gave the stock an “in-line” rating in a research note on Thursday, April 11th. Keefe, Bruyette & Woods upped their price target on shares of Allstate from $181.00 to $189.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th. Roth Mkm lifted their price objective on shares of Allstate from $175.00 to $200.00 and gave the stock a “buy” rating in a research note on Monday, April 8th. Piper Sandler upped their target price on Allstate from $172.00 to $188.00 and gave the company an “overweight” rating in a research report on Monday, April 1st. Finally, JPMorgan Chase & Co. lifted their price target on Allstate from $172.00 to $185.00 and gave the stock an “overweight” rating in a research report on Monday, April 8th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $173.71.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.